Gapmer‐type antisense oligonucleotides have not yet been approved for the treatment of central nervous system diseases, whereas steric‐blocking‐type antisense oligonucleotides have been well‐developed for clinical use. We here characterize a new type of double‐stranded oligonucleotides, overhanging‐duplex oligonucleotides, which are composed of the parent gapmer and its extended complementary RNA. By intracerebroventricular injection, overhanging oligonucleotides show greater silencing potency with more efficient delivery into mouse brains than the parent single‐stranded gapmer. Structure–activity relationship analyses reveal that the potency enhancement requires 13‐mer or more overhanging oligonucleotides with a phosphorothioate backbone. Overhanging oligonucleotides provide a new platform of therapeutic oligonucleotides for gene modulation in the central nervous system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.